Gene therapy: twenty-first century medicine
- PMID: 15952901
- DOI: 10.1146/annurev.biochem.74.050304.091637
Gene therapy: twenty-first century medicine
Abstract
Broadly defined, the concept of gene therapy involves the transfer of genetic material into a cell, tissue, or whole organ, with the goal of curing a disease or at least improving the clinical status of a patient. A key factor in the success of gene therapy is the development of delivery systems that are capable of efficient gene transfer in a variety of tissues, without causing any associated pathogenic effects. Vectors based upon many different viral systems, including retroviruses, lentiviruses, adenoviruses, and adeno-associated viruses, currently offer the best choice for efficient gene delivery. Their performance and pathogenicity has been evaluated in animal models, and encouraging results form the basis for clinical trials to treat genetic disorders and acquired diseases. Despite some initial success in these trials, vector development remains a seminal concern for improved gene therapy technologies.
Similar articles
-
Gene therapy with viral vectors.Annu Rev Pharmacol Toxicol. 2003;43:413-39. doi: 10.1146/annurev.pharmtox.43.100901.140257. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12359866 Review.
-
Development of hybrid viral vectors for gene therapy.Biotechnol Adv. 2013 Mar-Apr;31(2):208-23. doi: 10.1016/j.biotechadv.2012.10.001. Epub 2012 Oct 13. Biotechnol Adv. 2013. PMID: 23070017 Review.
-
[Gene therapy: new developments].Praxis (Bern 1994). 2002 Dec 18;91(51-52):2227-35. doi: 10.1024/0369-8394.91.51.2227. Praxis (Bern 1994). 2002. PMID: 12564039 Review. German.
-
Viral vectors for gene therapy.Trends Biotechnol. 1998 Jan;16(1):35-40. doi: 10.1016/S0167-7799(97)01137-2. Trends Biotechnol. 1998. PMID: 9470229 Review.
-
Viral vectors in gene therapy.Annu Rev Microbiol. 1995;49:807-38. doi: 10.1146/annurev.mi.49.100195.004111. Annu Rev Microbiol. 1995. PMID: 8561480 Review.
Cited by
-
Theranostic agents for intracellular gene delivery with spatiotemporal imaging.Nano Today. 2013 Feb 1;8(1):21-38. doi: 10.1016/j.nantod.2012.12.004. Nano Today. 2013. PMID: 23606894 Free PMC article.
-
Hypoxia and metabolic properties of hematopoietic stem cells.Antioxid Redox Signal. 2014 Apr 20;20(12):1891-901. doi: 10.1089/ars.2012.5019. Epub 2013 Jun 21. Antioxid Redox Signal. 2014. PMID: 23621582 Free PMC article. Review.
-
Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.PLoS One. 2012;7(12):e53492. doi: 10.1371/journal.pone.0053492. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300932 Free PMC article.
-
Recent advances in gene therapy: genetic bullets to the root of the problem.Clin Exp Med. 2023 Aug;23(4):1107-1121. doi: 10.1007/s10238-022-00925-x. Epub 2022 Oct 25. Clin Exp Med. 2023. PMID: 36284069 Review.
-
Antiviral RNAi therapy: emerging approaches for hitting a moving target.Gene Ther. 2006 Mar;13(6):532-40. doi: 10.1038/sj.gt.3302645. Gene Ther. 2006. PMID: 16177819 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical